nach oben

Erschienen in:

2021 | OriginalPaper | Buchkapitel

Nanomaterials for Medical Imaging and In Vivo Sensing

verfasst von : N. Ashwin Kumar, B. S. Suresh Anand, Ganapathy Krishnamurthy

Erschienen in: Nanomaterials and Their Biomedical Applications

Verlag: Springer Singapore

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Pre-clinical imaging is a technique that could help in investigating deep inside the rodents to obtain information regarding disease site and drug development process using a non-invasive approach. Diverse FDA approved contrast agents have been implemented since the evolution of these imaging technologies. The current limitations of these contrast agents include faster clearance and photo instability and could be unsuitable for multi-modal and hybrid imaging. These impediments can be overcome with the aid of developing new nanotechnology-based contrast agents. This opens up a new paradigm for researchers to visualize cancer to obtain nanomolecular information. During the past two decades, nano-based contrast agents have revolutionized pre-clinical imaging science, which offers to detect cancers early, rapidly, and effectively. Despite the fact, the concept and technology of imaging are old, the way we look at the disease using nanomaterials in a different perspective. Additionally, the imaging techniques combined with nanotechnology-based contrast agents can be used to investigate the interaction of drugs at a pre-clinical stage and the cellular level. Pre-clinical imaging is performed with two different strategies. The former techniques give anatomical information, which includes computed tomography, magnetic resonance imaging, and ultrasound. While the latter presents molecular information using optical techniques, photon-acoustic imaging, and positron emission tomography. Recent developments in nanotechnology-based contrast agents have opened new avenues to alter and improve the current imaging modalities resulting in hybrid and multi-modal imaging approaches. Here, we intend to provide fundamental knowledge and general considerations of using nanomaterials in pre-clinical imaging modalities. This chapter provides extensive information about the advancements in nanomaterials for pre-clinical imaging applications. In the later part, we discuss the science behind individual nanomaterials with different imaging systems and its improvements in pre-clinical imaging. Also, the advantages and drawbacks associated with nanomaterials are presented. Finally, we discuss the application of different nano-based contrast agents and their application in biomedical imaging.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Fabrication of Nanostructured Scaffolds for Tissue Engineering Applications

Nächstes Kapitel Nanomaterials: Surface Functionalization, Modification, and Applications

Cunha L, Horvath I, Ferreira S, Lemos J, Costa P, Vieira D, Veres DS, Szigeti K, Summavielle T, Mathe D, Metello LF (2014) Preclinical imaging: an essentially in modern biosciences. Mol Diagn Ther 18(2):153–173. https://doi.org/10.1007/s40291-013-0062-3CrossRef

Malikova MA (2016) Optimization of protocol design: a path to efficient, lower cost clinical trial execution. Future Sci OA 2(1):FSO89. https://doi.org/10.4155/fso.15.89

Bushberg JT, Seibert JA, Leidholdt EM, Boone JM (2011) The essential physics of medical imaging. Wolters Kluwer Health

Nune SK, Gunda P, Thallapally PK, Lin YY, Forrest ML, Berkland CJ (2009) Nanoparticles for biomedical imaging. Expert Opin Drug Deliv 6(11):1175–1194. https://doi.org/10.1517/17425240903229031CrossRef

McNamara K, Tofail SAM (2016) Nanoparticles in biomedical applications. Adv Phys: X 2(1):54–88. https://doi.org/10.1080/23746149.2016.1254570CrossRef

Smith BR, Gambhir SS (2017) Nanomaterials for in vivo imaging. Chem Rev 117(3):901–986. https://doi.org/10.1021/acs.chemrev.6b00073CrossRef

Yao R, Lecomte R, Crawford ES (2012) Small-animal PET: what is it, and why do we need it? J Nucl Med Technol 40(3):157–165. https://doi.org/10.2967/jnmt.111.098632CrossRef

Yang DJ, Kim EE, Inoue T (2006) Targeted molecular imaging in oncology. Ann Nucl Med 20(1):1–11. https://doi.org/10.1007/bf02985584CrossRef

Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG, Noullett C, Van Schaik A, Mitchell RT, Shibata MA, Gulamhussein S, McMeekin J, Tymchak W, Schnell G, Gillis AM, Sheldon RS, Fick GH, Duff HJ, Investigators R (2007) Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 50(24):2275–2284. https://doi.org/10.1016/j.jacc.2007.08.042CrossRef

10.

Seaman ME, Contino G, Bardeesy N, Kelly KA (2010) Molecular imaging agents: impact on diagnosis and therapeutics in oncology. Expert Rev Mol Med 12:e20. https://doi.org/10.1017/S1462399410001511CrossRef

11.

Pysz MA, Gambhir SS, Willmann JK (2010) Molecular imaging: current status and emerging strategies. Clin Radiol 65(7):500–516. https://doi.org/10.1016/j.crad.2010.03.011CrossRef

12.

Kim D, Kim J, Park YI, Lee N, Hyeon T (2018) Recent development of inorganic nanoparticles for biomedical imaging. ACS Cent Sci 4(3):324–336. https://doi.org/10.1021/acscentsci.7b00574CrossRef

13.

Nagai M, Kato K, Soga S, Santra TS, Shibata T (2020) Scalable parallel manipulation of single cells using micronozzle array integrated with bidirectional electrokinetic pumps. Micromachines (Basel) 11(4). https://doi.org/10.3390/mi11040442

14.

Peixoto L, Magalhães R, Navas D, Moraes S, Redondo C, Morales R, Araújo JP, Sousa CT (2020) Magnetic nanostructures for emerging biomedical applications. Appl Phys Rev 7(1):011310. https://doi.org/10.1063/1.5121702CrossRef

15.

Arms L, Smith DW, Flynn J, Palmer W, Martin A, Woldu A, Hua S (2018) Advantages and limitations of current techniques for analyzing the biodistribution of nanoparticles. Front Pharm 9:802. https://doi.org/10.3389/fphar.2018.00802CrossRef

16.

Dong YC, Hajfathalian M, Maidment PSN, Hsu JC, Naha PC, Si-Mohamed S, Breuilly M, Kim J, Chhour P, Douek P, Litt HI, Cormode DP (2019) Effect of gold nanoparticle size on their properties as contrast agents for computed tomography. Sci Rep 9(1):14912. https://doi.org/10.1038/s41598-019-50332-8ADSCrossRef

17.

Chen L, Xie J, Wu H, Li J, Wang Z, Song L, Zang F, Ma M, Gu N, Zhang Y (2018) Precise study on size-dependent properties of magnetic iron oxide nanoparticles for in vivo magnetic resonance imaging. J Nanomater 2018:1–9. https://doi.org/10.1155/2018/3743164CrossRef

18.

Marashdeh MW, Ababneh B, Lemine OM, Alsadig A, Omri K, El Mir L, Sulieman A, Mattar E (2019) The significant effect of size and concentrations of iron oxide nanoparticles on magnetic resonance imaging contrast enhancement. Results Phys 15:102651. https://doi.org/10.1016/j.rinp.2019.102651CrossRef

19.

Tamarov K, Nakki S, Xu W, Lehto VP (2018) Approaches to improve the biocompatibility and systemic circulation of inorganic porous nanoparticles. J Mater Chem B 6(22):3632–3649. https://doi.org/10.1039/c8tb00462eCrossRef

20.

Mout R, Moyano DF, Rana S, Rotello VM (2012) Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev 41(7):2539–2544. https://doi.org/10.1039/c2cs15294kCrossRef

21.

Pertici G (2017) Introduction to bioresorbable polymers for biomedical applications 3–29. https://doi.org/10.1016/b978-0-08-100262-9.00001-x

22.

Bohara RA, Thorat ND, Pawar SH (2016) Role of functionalization: strategies to explore potential nano-bio applications of magnetic nanoparticles. RSC Adv 6(50):43989–44012. https://doi.org/10.1039/c6ra02129hADSCrossRef

23.

Burrows ND, Vartanian AM, Abadeer NS, Grzincic EM, Jacob LM, Lin W, Li J, Dennison JM, Hinman JG, Murphy CJ (2016) Anisotropic nanoparticles and anisotropic surface chemistry. J Phys Chem Lett 7(4):632–641. https://doi.org/10.1021/acs.jpclett.5b02205CrossRef

24.

Shinde P, Kumar A, Kavitha, Dey K, Mohan L, Kar S, Barik TK, Sharifi-Rad J, Nagai M, Santra TS (2020) Physical approaches for drug delivery, pp 161–190. https://doi.org/10.1016/b978-0-12-817776-1.00007-9

25.

Santra TS, Chen C-W, Chang H-Y, Tseng F-G (2016) Dielectric passivation layer as a substratum on localized single-cell electroporation. RSC Adv 6(13):10979–10986. https://doi.org/10.1039/c5ra18258aADSCrossRef

26.

Santra TS, Tseng F-G (2016) Electroporation for single-cell analysis, pp 55–83. https://doi.org/10.1007/978-3-662-49118-8_3

27.

Santra TS, Kar S, Borana J, Wang P-C, Tseng F-G (2014) Nanolocalized single-cell-membrane nanoelectroporation: for higher efficiency with high cell viability. IEEE Nanatechnol Mag 8(1):30–34. https://doi.org/10.1109/mnano.2014.2312031CrossRef

28.

Mohan L, Kar S, Nandhini B, Dhilip Kumar SS, Nagai M, Santra TS (2020) Formation of nanostructures on magnesium alloy by anodization for potential biomedical applications. Mater Today Commun 25:101403. http://doi.org/10.1016/j.mtcomm.2020.101403

29.

Shinde P, Kar S, Loganathan M, Chang H-Y, Tseng F-G, Nagai M, Santra TS (2020) Infrared pulse laser-activated highly efficient intracellular delivery using titanium microdish device. ACS Biomater Sci Eng 6(10):5645–5652. https://doi.org/10.1021/acsbiomaterials.0c00785CrossRef

30.

Kohout C, Santi C, Polito L (2018) Anisotropic gold nanoparticles in biomedical applications. Int J Mol Sci 19(11). https://doi.org/10.3390/ijms19113385

31.

Cotin G, Perton F, Blanco-Andujar C, Pichon B, Mertz D, Bégin-Colin S (2019) Design of anisotropic iron-oxide-based nanoparticles for magnetic hyperthermia, pp 41–60. https://doi.org/10.1016/b978-0-12-813928-8.00002-8

32.

Nikitin AA, Khramtsov MA, Savchenko AG, Abakumov MA, Mazhuga AG (2018) Anisotropic iron-oxide nanoparticles for diagnostic MRI: synthesis and contrast properties. Pharm Chem J 52(3):231–235. https://doi.org/10.1007/s11094-018-1796-3CrossRef

33.

Min Y, Caster JM, Eblan MJ, Wang AZ (2015) Clinical translation of nanomedicine. Chem Rev 115(19):11147–11190. https://doi.org/10.1021/acs.chemrev.5b00116CrossRef

34.

Paefgen V, Doleschel D, Kiessling F (2015) Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery. Front Pharm 6:197. https://doi.org/10.3389/fphar.2015.00197CrossRef

35.

Han X, Xu K, Taratula O, Farsad K (2019) Applications of nanoparticles in biomedical imaging. Nanoscale 11(3):799–819. https://doi.org/10.1039/c8nr07769jCrossRef

36.

Lee DE, Koo H, Sun IC, Ryu JH, Kim K, Kwon IC (2012) Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev 41(7):2656–2672. https://doi.org/10.1039/c2cs15261dCrossRef

37.

Weissman NJ, Soman P, Shah DJ (2013) Multimodality imaging: opportunities and challenges. JACC Cardiovasc Imaging 6(9):1022–1023. https://doi.org/10.1016/j.jcmg.2013.07.003CrossRef

38.

Liu Z, Kiessling F, Gätjens J (2010) Advanced nanomaterials in multimodal imaging: design, functionalization, and biomedical applications. J Nanomater 2010:1–15. https://doi.org/10.1155/2010/894303CrossRef

39.

Santra TS, Tseng FG (2020) Single-cell analysis. Cells 9(9). https://doi.org/10.3390/cells9091993

40.

Santra TS, Kar S, Chang HY, Tseng FG (2020) Nano-localized single-cell nano-electroporation. Lab Chip. https://doi.org/10.1039/d0lc00712aCrossRef

41.

Davison CA, Chapman SE, Sasser TA, Wathen C, Diener J, Schafer ZT, M. Leevy WM (2013) Multimodal optical, X-Ray CT, and SPECT imaging of a mouse model of breast cancer lung metastasis. Curr Mol Med 13(3):368–376. http://doi.org/10.2174/1566524011313030006

42.

Key J, Leary JF (2014) Nanoparticles for multimodal in vivo imaging in nanomedicine. Int J Nanomed 9:711–726. https://doi.org/10.2147/IJN.S53717CrossRef

43.

Leblond F, Davis SC, Valdes PA, Pogue BW (2010) Pre-clinical whole-body fluorescence imaging: review of instruments, methods and applications. J Photochem Photobiol, B 98(1):77–94. https://doi.org/10.1016/j.jphotobiol.2009.11.007CrossRef

44.

Retif P, Pinel S, Toussaint M, Frochot C, Chouikrat R, Bastogne T, Barberi-Heyob M (2015) Nanoparticles for radiation therapy enhancement: the key parameters. Theranostics 5(9):1030–1044. https://doi.org/10.7150/thno.11642CrossRef

45.

Shan L, Chopra A, Leung K, Eckelman WC, Menkens AE (2012) Characterization of nanoparticle-based contrast agents for molecular magnetic resonance imaging. J Nanoparticle Res 14(9). https://doi.org/10.1007/s11051-012-1122-z

46.

Glasser O (1995) W. C. Roentgen and the discovery of the Roentgen rays. AJR Am J roentgenol 165(5):1033–1040. https://doi.org/10.2214/ajr.165.5.7572472

47.

Goodman PC (1995) The new light: discovery and introduction of the X-ray. AJR Am J Roentgenol 165(5):1041–1045. https://doi.org/10.2214/ajr.165.5.7572473CrossRef

48.

B SL, Sai Varsha MKN, Kumar NA, Dixit M, Krishnamurthi G (2017) Fast frame rate rodent cardiac x-ray imaging using scintillator lens coupled to CMOS camera 10132:101322 K. https://doi.org/10.1117/12.2254541

49.

Lee N, Choi SH, Hyeon T (2013) Nano-sized CT contrast agents. Adv Mater 25(19):2641–2660. https://doi.org/10.1002/adma.201300081CrossRef

50.

Gazelle GS, Wolf GL, McIntire GL, Bacon ER, Halpern EF, Cooper ER, Toner JL (1994) Nanoparticulate computed tomography contrast agents for blood pool and liver-spleen imaging. Acad Radiol 1(4):373–376. https://doi.org/10.1016/s1076-6332(12)80011-0CrossRef

51.

Pasternak JJ, Williamson EE (2012) Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist. Mayo Clin Proc 87(4):390–402. https://doi.org/10.1016/j.mayocp.2012.01.012CrossRef

52.

Yin Q, Yap FY, Yin L, Ma L, Zhou Q, Dobrucki LW, Fan TM, Gaba RC, Cheng J (2013) Poly(iohexol) nanoparticles as contrast agents for in vivo X-ray computed tomography imaging. J Am Chem Soc 135(37):13620–13623. https://doi.org/10.1021/ja405196fCrossRef

53.

de Vries A, Custers E, Lub J, van den Bosch S, Nicolay K, Grull H (2010) Block-copolymer-stabilized iodinated emulsions for use as CT contrast agents. Biomaterials 31(25):6537–6544. https://doi.org/10.1016/j.biomaterials.2010.04.056CrossRef

54.

Kim H, Lee SK, Kim YM, Lee EH, Lim SJ, Kim SH, Yang J, Lim JS, Hyung WJ (2015) Fluorescent iodized emulsion for pre- and intraoperative sentinel lymph node imaging: validation in a preclinical model. Radiology 275(1):196–204. https://doi.org/10.1148/radiol.14141159CrossRef

55.

Hainfeld JF, Ridwan SM, Stanishevskiy Y, Smilowitz NR, Davis J, Smilowitz HM (2018) Small, long blood half-life iodine nanoparticle for vascular and tumor imaging. Sci Rep 8(1):13803. https://doi.org/10.1038/s41598-018-31940-2ADSCrossRef

56.

Zou Q, Huang J, Zhang X (2018) One-step synthesis of iodinated polypyrrole nanoparticles for CT imaging guided photothermal therapy of tumors. Small 14(45):e1803101. https://doi.org/10.1002/smll.201803101CrossRef

57.

Heiligtag FJ, Niederberger M (2013) The fascinating world of nanoparticle research. Mater Today 16(7–8):262–271. https://doi.org/10.1016/j.mattod.2013.07.004CrossRef

58.

Banstola A, Emami F, Jeong J-H, Yook S (2018) Current applications of gold nanoparticles for medical imaging and as treatment agents for managing pancreatic cancer. Macromol Res 26(11):955–964. https://doi.org/10.1007/s13233-018-6139-4CrossRef

59.

Cole LE, Ross RD, Tilley JM, Vargo-Gogola T, Roeder RK (2015) Gold nanoparticles as contrast agents in x-ray imaging and computed tomography. Nanomedicine (Lond) 10(2):321–341. https://doi.org/10.2217/nnm.14.171CrossRef

60.

Xi D, Dong S, Meng X, Lu Q, Meng L, Ye J (2012) Gold nanoparticles as computerized tomography (CT) contrast agents. RSC Adv 2(33):12515. https://doi.org/10.1039/c2ra21263cADSCrossRef

61.

Ide JM, Lancelot E, Pines E, Corot C (2004) Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view. Invest Radiol 39(3):155–170. https://doi.org/10.1097/01.rli.0000101483.60710.2cCrossRef

62.

Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM (2006) Gold nanoparticles: a new X-ray contrast agent. The Br J Radiol 79(939):248–253. https://doi.org/10.1259/bjr/13169882CrossRef

63.

Ross RD, Cole LE, Tilley JMR, Roeder RK (2014) Effects of functionalized gold nanoparticle size on X-ray attenuation and substrate binding affinity. Chem Mater 26(2):1187–1194. https://doi.org/10.1021/cm4035616CrossRef

64.

Kattumuri V, Katti K, Bhaskaran S, Boote EJ, Casteel SW, Fent GM, Robertson DJ, Chandrasekhar M, Kannan R, Katti KV (2007) Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies. Small 3(2):333–341. https://doi.org/10.1002/smll.200600427CrossRef

65.

Kim D, Park S, Lee JH, Jeong YY, Jon S (2007) Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 129(24):7661–7665. https://doi.org/10.1021/ja071471pCrossRef

66.

Peng C, Zheng L, Chen Q, Shen M, Guo R, Wang H, Cao X, Zhang G, Shi X (2012) PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials 33(4):1107–1119. https://doi.org/10.1016/j.biomaterials.2011.10.052CrossRef

67.

Kojima C, Umeda Y, Ogawa M, Harada A, Magata Y, Kono K (2010) X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer. Nanotechnology 21(24):245104. https://doi.org/10.1088/0957-4484/21/24/245104ADSCrossRef

68.

Zhang XD, Wu D, Shen X, Liu PX, Yang N, Zhao B, Zhang H, Sun YM, Zhang LA, Fan FY (2011) Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomed 6:2071–2081. https://doi.org/10.2147/IJN.S21657CrossRef

69.

Zhang XD, Wu HY, Wu D, Wang YY, Chang JH, Zhai ZB, Meng AM, Liu PX, Zhang LA, Fan FY (2010) Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomed 5:771–781. https://doi.org/10.2147/IJN.S8428CrossRef

70.

Zhang XD, Wu D, Shen X, Chen J, Sun YM, Liu PX, Liang XJ (2012) Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 33(27):6408–6419. https://doi.org/10.1016/j.biomaterials.2012.05.047CrossRef

71.

Srinoi P, Chen Y-T, Vittur V, Marquez M, Lee T (2018) Bimetallic nanoparticles: enhanced magnetic and optical properties for emerging biological applications. Appl Sci 8(7):1106. https://doi.org/10.3390/app8071106CrossRef

72.

Naha PC, Lau KC, Hsu JC, Hajfathalian M, Mian S, Chhour P, Uppuluri L, McDonald ES, Maidment AD, Cormode DP (2016) Gold silver alloy nanoparticles (GSAN): an imaging probe for breast cancer screening with dual-energy mammography or computed tomography. Nanoscale 8(28):13740–13754. https://doi.org/10.1039/c6nr02618dADSCrossRef

73.

Wang H, Zheng L, Guo R, Peng C, Shen M, Shi X, Zhang G (2012) Dendrimer-entrapped gold nanoparticles as potential CT contrast agents for blood pool imaging. Nanoscale Res Lett 7:190. https://doi.org/10.1186/1556-276X-7-190ADSCrossRef

74.

Chu Z, Chen L, Wang X, Yang Q, Zhao Q, Huang C, Huang Y, Yang D-P, Jia N (2019) Ultrasmall Au–Ag alloy nanoparticles: protein-directed synthesis, biocompatibility, and X-ray computed tomography imaging. ACS Biomater Sci Eng 5(2):1005–1015. https://doi.org/10.1021/acsbiomaterials.8b01176CrossRef

75.

Gui C, Cui DX (2012) Functionalized gold nanorods for tumor imaging and targeted therapy. Cancer Biol Med 9(4):221–233. https://doi.org/10.7497/j.issn.2095-3941.2012.04.002CrossRef

76.

Reuveni T, Motiei M, Romman Z, Popovtzer A, Popovtzer R (2011) Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomed 6:2859–2864. https://doi.org/10.2147/IJN.S25446CrossRef

77.

Jazayeri MH, Amani H, Pourfatollah AA, Pazoki-Toroudi H, Sedighimoghaddam B (2016) Various methods of gold nanoparticles (GNPs) conjugation to antibodies. Sens Bio-Sens Res 9:17–22. https://doi.org/10.1016/j.sbsr.2016.04.002CrossRef

78.

Gupta P, Balasubramaniam N, Chang HY, Tseng FG, Santra TS (2020) A single-neuron: current trends and future prospects. Cells 9(6). https://doi.org/10.3390/cells9061528

79.

Kruger CA, Abrahamse H (2018) Utilisation of targeted nanoparticle photosensitiser drug delivery systems for the enhancement of photodynamic therapy. Molecules 23(10). https://doi.org/10.3390/molecules23102628

80.

Rosenblum D, Joshi N, Tao W, Karp JM, Peer D (2018) Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun 9(1):1410. https://doi.org/10.1038/s41467-018-03705-yADSCrossRef

81.

Zhou B, Yang J, Peng C, Zhu J, Tang Y, Zhu X, Shen M, Zhang G, Shi X (2016) PEGylated polyethylenimine-entrapped gold nanoparticles modified with folic acid for targeted tumor CT imaging. Colloids Surf B Biointerfaces 140:489–496. https://doi.org/10.1016/j.colsurfb.2016.01.019CrossRef

82.

Eck W, Nicholson AI, Zentgraf H, Semmler W, Bartling S (2010) Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in X-ray computed tomography of live mice. Nano Lett 10(7):2318–2322. https://doi.org/10.1021/nl101019sADSCrossRef

83.

Li X, Wang C, Tan H, Cheng L, Liu G, Yang Y, Zhao Y, Zhang Y, Li Y, Zhang C, Xiu Y, Cheng D, Shi H (2016) Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques. Biomaterials 108:71–80. https://doi.org/10.1016/j.biomaterials.2016.08.048CrossRef

84.

Khademi S, Sarkar S, Shakeri-Zadeh A, Attaran N, Kharrazi S, Ay MR, Ghadiri H (2018) Folic acid-cysteamine modified gold nanoparticle as a nanoprobe for targeted computed tomography imaging of cancer cells. Mater Sci Eng C Mater Biol Appl 89:182–193. https://doi.org/10.1016/j.msec.2018.03.015CrossRef

85.

Zhu XY, Zou X, Mukherjee R, Yu Z, Ferguson CM, Zhou W, McCollough CH, Lerman LO (2018) Targeted imaging of renal fibrosis using antibody-conjugated gold nanoparticles in renal artery stenosis. Invest Radiol 53(10):623–628. https://doi.org/10.1097/RLI.0000000000000476CrossRef

86.

Shang L, Dong S, Nienhaus GU (2011) Ultra-small fluorescent metal nanoclusters: synthesis and biological applications. Nano Today 6(4):401–418. https://doi.org/10.1016/j.nantod.2011.06.004CrossRef

87.

Zhang XD, Wu D, Shen X, Liu PX, Fan FY, Fan SJ (2012) In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials 33(18):4628–4638. https://doi.org/10.1016/j.biomaterials.2012.03.020CrossRef

88.

Zhou C, Long M, Qin Y, Sun X, Zheng J (2011) Luminescent gold nanoparticles with efficient renal clearance. Angew Chem 50(14):3168–3172. https://doi.org/10.1002/anie.201007321CrossRef

89.

Liu Y, Tian GF, He XW, Li WY, Zhang YK (2016) Microwave-assisted one-step rapid synthesis of near-infrared gold nanoclusters for NIRF/CT dual-modal bioimaging. J Mater Chem B 4(7):1276–1283. https://doi.org/10.1039/c5tb02322jCrossRef

90.

Jia TT, Yang G, Mo SJ, Wang ZY, Li BJ, Ma W, Guo YX, Chen X, Zhao X, Liu JQ, Zang SQ (2019) Atomically precise gold-levonorgestrel nanocluster as a radiosensitizer for enhanced cancer therapy. ACS Nano 13(7):8320–8328. https://doi.org/10.1021/acsnano.9b03767CrossRef

91.

Zhang Q, Yang M, Zhu Y, Mao C (2018) Metallic nanoclusters for cancer imaging and therapy. Curr Med Chem 25(12):1379–1396. https://doi.org/10.2174/0929867324666170331122757CrossRef

92.

Zhang C, Li C, Liu Y, Zhang J, Bao C, Liang S, Wang Q, Yang Y, Fu H, Wang K, Cui D (2015) Gold nanoclusters-based nanoprobes for simultaneous fluorescence imaging and targeted photodynamic therapy with superior penetration and retention behavior in tumors. Adv Func Mater 25(8):1314–1325. https://doi.org/10.1002/adfm.201403095CrossRef

93.

Yu S, Wen R, Wang H, Zha Y, Qiu L, Li B, Xue W, Ma D (2019) Chitosan-graft-Poly(l-lysine) dendron-assisted facile self-assembly of au nanoclusters for enhanced X-ray computer tomography imaging and precise MMP-9 plasmid shRNA delivery. Chem Mater 31(11):3992–4007. https://doi.org/10.1021/acs.chemmater.9b00507CrossRef

94.

Winter H, Brown AL, Goforth AM (2018) Bismuth-based nano- and microparticles in X-ray contrast, radiation therapy, and radiation shielding applications. http://doi.org/10.5772/intechopen.76413

95.

Wang Y, Wu Y, Liu Y, Shen J, Lv L, Li L, Yang L, Zeng J, Wang Y, Zhang LW, Li Z, Gao M, Chai Z (2016) BSA-mediated synthesis of bismuth sulfide nanotheranostic agents for tumor multimodal imaging and thermoradiotherapy. Adv Func Mater 26(29):5335–5344. https://doi.org/10.1002/adfm.201601341CrossRef

96.

Shahbazi MA, Faghfouri L, Ferreira MPA, Figueiredo P, Maleki H, Sefat F, Hirvonen J, Santos HA (2020) The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties. Chem Soc Rev 49(4):1253–1321. https://doi.org/10.1039/c9cs00283aCrossRef

97.

Brown AL, Naha PC, Benavides-Montes V, Litt HI, Goforth AM, Cormode DP (2014) Synthesis, X-ray opacity, and biological compatibility of ultra-high payload elemental bismuth nanoparticle X-ray contrast agents. Chem Mater: A Publ Am Chem Soc 26(7):2266–2274. https://doi.org/10.1021/cm500077zCrossRef

98.

Rabin O, Manuel Perez J, Grimm J, Wojtkiewicz G, Weissleder R (2006) An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 5(2):118–122. https://doi.org/10.1038/nmat1571ADSCrossRef

99.

Pan D, Williams TA, Senpan A, Allen JS, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM (2009) Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle. J Am Chem Soc 131(42):15522–15527. https://doi.org/10.1021/ja906797zCrossRef

100.

Ai K, Liu Y, Liu J, Yuan Q, He Y, Lu L (2011) Large-scale synthesis of Bi(2)S(3) nanodots as a contrast agent for in vivo X-ray computed tomography imaging. Adv Mater 23(42):4886–4891. https://doi.org/10.1002/adma.201103289CrossRef

101.

Liu J, Zheng X, Yan L, Zhou L, Tian G, Yin W, Wang L, Liu Y, Hu Z, Gu Z, Chen C, Zhao Y (2015) Bismuth sulfide nanorods as a precision nanomedicine for in vivo multimodal imaging-guided photothermal therapy of tumor. ACS Nano 9(1):696–707. https://doi.org/10.1021/nn506137nCrossRef

102.

Yu X, Li A, Zhao C, Yang K, Chen X, Li W (2017) Ultrasmall semimetal nanoparticles of bismuth for dual-modal computed tomography/photoacoustic imaging and synergistic thermoradiotherapy. ACS Nano 11(4):3990–4001. https://doi.org/10.1021/acsnano.7b00476CrossRef

103.

Roy B, Chattopadhyay AP, Samadder A, Khuda-Bukhsh AR (2015) Target synthesis of biocompatible spherical bismuth sulphide nanoparticles for biological application. J Sol-Gel Sci Technol 77(2):446–452. https://doi.org/10.1007/s10971-015-3873-3CrossRef

104.

Kinsella JM, Jimenez RE, Karmali PP, Rush AM, Kotamraju VR, Gianneschi NC, Ruoslahti E, Stupack D, Sailor MJ (2011) X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew Chem 50(51):12308–12311. https://doi.org/10.1002/anie.201104507CrossRef

105.

Li L, Lu Y, Jiang C, Zhu Y, Yang X, Hu X, Lin Z, Zhang Y, Peng M, Xia H, Mao C (2018) Actively targeted deep tissue imaging and photothermal-chemo therapy of breast cancer by antibody-functionalized drug-loaded X-ray-responsive bismuth sulfide@mesoporous silica core-shell nanoparticles. Adv Funct Mater 28(5). https://doi.org/10.1002/adfm.201704623

106.

Nosrati H, Abhari F, Charmi J, Rahmati M, Johari B, Azizi S, Rezaeejam H, Danafar H (2019) Facile green synthesis of bismuth sulfide radiosensitizer via biomineralization of albumin natural molecule for chemoradiation therapy aim. Artif Cells Nanomed Biotechnol 47(1):3832–3838. https://doi.org/10.1080/21691401.2019.1669624CrossRef

107.

Azizi S, Nosrati H, Sharafi A, Danafar H (2019) Preparation of bismuth sulfide nanoparticles as targeted biocompatible nano‐radiosensitizer and carrier of methotrexate. Appl Organomet Chem 34(1). https://doi.org/10.1002/aoc.5251

108.

Nosrati H, Charmi J, Salehiabar M, Abhari F, Danafar H (2019) Tumor targeted albumin coated bismuth sulfide nanoparticles (Bi2S3) as radiosensitizers and carriers of curcumin for enhanced chemoradiation therapy. ACS Biomater Sci Eng 5(9):4416–4424. https://doi.org/10.1021/acsbiomaterials.9b00489CrossRef

109.

Zhou D, Li C, He M, Ma M, Li P, Gong Y, Ran H, Wang Z, Wang Z, Zheng Y, Sun Y (2016) Folate-targeted perfluorohexane nanoparticles carrying bismuth sulfide for use in US/CT dual-mode imaging and synergistic high-intensity focused ultrasound ablation of cervical cancer. J Mater Chem B 4(23):4164–4181. https://doi.org/10.1039/c6tb00261gCrossRef

110.

Oh MH, Lee N, Kim H, Park SP, Piao Y, Lee J, Jun SW, Moon WK, Choi SH, Hyeon T (2011) Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem Soc 133(14):5508–5515. https://doi.org/10.1021/ja200120kCrossRef

111.

Matsuno H (2001) Biocompatibility and osteogenesis of refractory metal implants, titanium, hafnium, niobium, tantalum and rhenium. Biomaterials 22(11):1253–1262. https://doi.org/10.1016/s0142-9612(00)00275-1CrossRef

112.

Bonitatibus PJ Jr, Torres AS, Kandapallil B, Lee BD, Goddard GD, Colborn RE, Marino ME (2012) Preclinical assessment of a zwitterionic tantalum oxide nanoparticle X-ray contrast agent. ACS Nano 6(8):6650–6658. https://doi.org/10.1021/nn300928gCrossRef

113.

Lee N, Yoo D, Ling D, Cho MH, Hyeon T, Cheon J (2015) Iron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapy. Chem Rev 115(19):10637–10689. https://doi.org/10.1021/acs.chemrev.5b00112CrossRef

114.

Torres AS, Bonitatibus PJ Jr, Colborn RE, Goddard GD, FitzGerald PF, Lee BD, Marino ME (2012) Biological performance of a size-fractionated core-shell tantalum oxide nanoparticle x-ray contrast agent. Invest Radiol 47(10):578–587. https://doi.org/10.1097/RLI.0b013e318260fc40CrossRef

115.

Freedman JD, Lusic H, Snyder BD, Grinstaff MW (2014) Tantalum oxide nanoparticles for the imaging of articular cartilage using X-ray computed tomography: visualization of ex vivo/in vivo murine tibia and ex vivo human index finger cartilage. Angew Chem 53(32):8406–8410. https://doi.org/10.1002/anie.201404519CrossRef

116.

Crowder JM, Bates N, Roberts J, Torres AS, Bonitatibus PJ (2016) Determination of tantalum from tantalum oxide nanoparticle X-ray/CT contrast agents in rat tissues and bodily fluids by ICP-OES. J Anal At Spectrom 31(6):1311–1317. https://doi.org/10.1039/c5ja00446bCrossRef

117.

Song G, Chen Y, Liang C, Yi X, Liu J, Sun X, Shen S, Yang K, Liu Z (2016) Catalase-loaded taox nanoshells as bio-nanoreactors combining high-Z element and enzyme delivery for enhancing radiotherapy. Adv Mater 28(33):7143–7148. https://doi.org/10.1002/adma.201602111CrossRef

118.

Chen Y, Song G, Dong Z, Yi X, Chao Y, Liang C, Yang K, Cheng L, Liu Z (2017) Drug-loaded mesoporous tantalum oxide nanoparticles for enhanced synergetic chemoradiotherapy with reduced systemic toxicity. Small 13(8). https://doi.org/10.1002/smll.201602869

119.

Jin Y, Ma X, Zhang S, Meng H, Xu M, Yang X, Xu W, Tian J (2017) A tantalum oxide-based core/shell nanoparticle for triple-modality image-guided chemo-thermal synergetic therapy of esophageal carcinoma. Cancer Lett 397:61–71. https://doi.org/10.1016/j.canlet.2017.03.030CrossRef

120.

Peng C, Liang Y, Chen Y, Qian X, Luo W, Chen S, Zhang S, Dan Q, Zhang L, Li M, Yuan M, Zhao B, Li Y (2020) Hollow mesoporous tantalum oxide based nanospheres for triple sensitization of radiotherapy. ACS Appl Mater Interfaces 12(5):5520–5530. https://doi.org/10.1021/acsami.9b20053CrossRef

121.

Rajasekar S, Martin EM, Kuppusamy S, Vetrivel C (2020) Chitosan coated molybdenum sulphide nanosheet incorporated with tantalum oxide nanomaterials for improving cancer photothermal therapy. Arab J Chem 13(3):4741–4750. https://doi.org/10.1016/j.arabjc.2019.11.005CrossRef

122.

Xiao Q, Bu W, Ren Q, Zhang S, Xing H, Chen F, Li M, Zheng X, Hua Y, Zhou L, Peng W, Qu H, Wang Z, Zhao K, Shi J (2012) Radiopaque fluorescence-transparent TaOx decorated upconversion nanophosphors for in vivo CT/MR/UCL trimodal imaging. Biomaterials 33(30):7530–7539. https://doi.org/10.1016/j.biomaterials.2012.06.028CrossRef

123.

Chakravarty S, Hix JML, Wiewiora KA, Volk MC, Kenyon E, Shuboni-Mulligan DD, Blanco-Fernandez B, Kiupel M, Thomas J, Sempere LF, Shapiro EM (2020) Tantalum oxide nanoparticles as versatile contrast agents for X-ray computed tomography. Nanoscale. https://doi.org/10.1039/d0nr01234cCrossRef

124.

Liu Y, Liu J, Ai K, Yuan Q, Lu L (2014) Recent advances in ytterbium-based contrast agents for in vivo X-ray computed tomography imaging: promises and prospects. Contrast Media Mol Imaging 9(1):26–36. https://doi.org/10.1002/cmmi.1537CrossRef

125.

Xiong L, Yang T, Yang Y, Xu C, Li F (2010) Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 31(27):7078–7085. https://doi.org/10.1016/j.biomaterials.2010.05.065CrossRef

126.

Wachter J (1990) The elements. Von J. Emsley. Clarendon Press, Oxford 1989. 256 S., Paperback £ 9.95. ISBN 0-19-855237-8. Angewandte Chemie 102(1):115–115. https://doi.org/10.1002/ange.19901020140

127.

Li Z, Zhang Y, Jiang S (2008) Multicolor core/shell-structured upconversion fluorescent nanoparticles. Adv Mater 20(24):4765–4769. https://doi.org/10.1002/adma.200801056CrossRef

128.

Unger E, Gutierrez F (1986) Ytterbium-DTPA. A potential intravascular contrast agent. Investig Radiol 21(10):802–807. https://doi.org/10.1097/00004424-198610000-00007

129.

Krause W, Schuhmann-Giampieri G, Bauer M, Press W-R, Muschick P (1996) Ytterbium- and dysprosium-EOB-DTPA: a new prototype of liver-specific contrast agents for computed tomography. Investig Radiol 31(8):502–511

130.

Schmitz SA, Wagner S, Schuhmann-Giampieri G, Krause W, Bollow M, Wolf KJ (1997) Gd-EOB-DTPA and Yb-EOB-DTPA: two prototypic contrast media for CT detection of liver lesions in dogs. Radiology 205(2):361–366. https://doi.org/10.1148/radiology.205.2.9356615CrossRef

131.

Anbazhagan R, Su YA, Tsai HC, Jeng RJ (2016) MoS2-Gd chelate magnetic nanomaterials with core-shell structure used as contrast agents in in vivo magnetic resonance imaging. ACS Appl Mater Interfaces 8(3):1827–1835. https://doi.org/10.1021/acsami.5b09722CrossRef

132.

Liu Y, Ai K, Liu J, Yuan Q, He Y, Lu L (2012) A high-performance ytterbium-based nanoparticulate contrast agent for in vivo X-ray computed tomography imaging. Angew Chem 51(6):1437–1442. https://doi.org/10.1002/anie.201106686CrossRef

133.

Liu Y, Ai K, Liu J, Yuan Q, He Y, Lu L (2012) Hybrid BaYbF(5) nanoparticles: novel binary contrast agent for high-resolution in vivo X-ray computed tomography angiography. Adv Healthc Mater 1(4):461–466. https://doi.org/10.1002/adhm.201200028CrossRef

134.

Liu Z, Pu F, Liu J, Jiang L, Yuan Q, Li Z, Ren J, Qu X (2013) PEGylated hybrid ytterbia nanoparticles as high-performance diagnostic probes for in vivo magnetic resonance and X-ray computed tomography imaging with low systemic toxicity. Nanoscale 5(10):4252–4261. https://doi.org/10.1039/c3nr00491kADSCrossRef

135.

Liu Z, Li Z, Liu J, Gu S, Yuan Q, Ren J, Qu X (2012) Long-circulating Er3+-doped Yb2O3 up-conversion nanoparticle as an in vivo X-Ray CT imaging contrast agent. Biomaterials 33(28):6748–6757. https://doi.org/10.1016/j.biomaterials.2012.06.033CrossRef

136.

Zeng S, Tsang MK, Chan CF, Wong KL, Hao J (2012) PEG modified BaGdF(5):Yb/Er nanoprobes for multi-modal upconversion fluorescent, in vivo X-ray computed tomography and biomagnetic imaging. Biomaterials 33(36):9232–9238. https://doi.org/10.1016/j.biomaterials.2012.09.019CrossRef

137.

Pan D, Schirra CO, Senpan A, Schmieder AH, Stacy AJ, Roessl E, Thran A, Wickline SA, Proska R, Lanza GM (2012) An early investigation of ytterbium nanocolloids for selective and quantitative “multicolor” spectral CT imaging. ACS Nano 6(4):3364–3370. https://doi.org/10.1021/nn300392xCrossRef

138.

Liu Z, Pu F, Huang S, Yuan Q, Ren J, Qu X (2013) Long-circulating Gd(2)O(3):Yb(3+), Er(3+) up-conversion nanoprobes as high-performance contrast agents for multi-modality imaging. Biomaterials 34(6):1712–1721. https://doi.org/10.1016/j.biomaterials.2012.11.009CrossRef

139.

Liu JN, Bu W, Pan LM, Zhang S, Chen F, Zhou L, Zhao KL, Peng W, Shi J (2012) Simultaneous nuclear imaging and intranuclear drug delivery by nuclear-targeted multifunctional upconversion nanoprobes. Biomaterials 33(29):7282–7290. https://doi.org/10.1016/j.biomaterials.2012.06.035CrossRef

140.

Xia A, Chen M, Gao Y, Wu D, Feng W, Li F (2012) Gd3+ complex-modified NaLuF4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-Ray computed tomography and magnetic resonance. Biomaterials 33(21):5394–5405. https://doi.org/10.1016/j.biomaterials.2012.04.025CrossRef

141.

McCollough CH, Leng S, Yu L, Fletcher JG (2015) Dual- and multi-energy CT: principles, technical approaches, and clinical applications. Radiology 276(3):637–653. https://doi.org/10.1148/radiol.2015142631CrossRef

142.

French J, Gingles N, Stewart J, Woodhouse N (2010) Use of magnetic resonance imaging (MRI) and micro-computed tomography (micro-CT) in the morphological examination of rat and rabbit fetuses from embryo-fetal development studies. Reprod Toxicol 30(2):292–300. https://doi.org/10.1016/j.reprotox.2010.04.016CrossRef

143.

Na HB, Song IC, Hyeon T (2009) Inorganic nanoparticles for MRI contrast agents. Adv Mater 21(21):2133–2148. https://doi.org/10.1002/adma.200802366CrossRef

144.

Constantinides C (2016) Magnetic resonance imaging: the basics. CRC Press

145.

Driehuys B, Nouls J, Badea A, Bucholz E, Ghaghada K, Petiet A, Hedlund LW (2008) Small animal imaging with magnetic resonance microscopy. ILAR J 49(1):35–53. https://doi.org/10.1093/ilar.49.1.35CrossRef

146.

Turnbull DH, Mori S (2007) MRI in mouse developmental biology. NMR Biomed 20(3):265–274. https://doi.org/10.1002/nbm.1146CrossRef

147.

Schaeffter T, Dahnke H (2008) Magnetic resonance imaging and spectroscopy. Handb Exp Pharmacol (185 Pt 1):75–90. https://doi.org/10.1007/978-3-540-72718-7_4

148.

Wahsner J, Gale EM, Rodriguez-Rodriguez A, Caravan P (2019) Chemistry of MRI contrast agents: current challenges and new frontiers. Chem Rev 119(2):957–1057. https://doi.org/10.1021/acs.chemrev.8b00363CrossRef

149.

Geraldes CF, Laurent S (2009) Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging 4(1):1–23. https://doi.org/10.1002/cmmi.265CrossRef

150.

De Leon-Rodriguez LM, Martins AF, Pinho MC, Rofsky NM, Sherry AD (2015) Basic MR relaxation mechanisms and contrast agent design. J Magnetic Reson Imaging: JMRI 42(3):545–565. https://doi.org/10.1002/jmri.24787CrossRef

151.

Young IR, Clarke GJ, Baffles DR, Pennock JM, Doyle FH, Bydder GM (1981) Enhancement of relaxation rate with paramagnetic contrast agents in NMR imaging. J Comput Tomogr 5(6):543–547. https://doi.org/10.1016/0149-936x(81)90089-8CrossRef

152.

Carr DH, Brown J, Bydder GM, Weinmann HJ, Speck U, Thomas DJ, Young IR (1984) Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. The Lancet 323(8375):484–486. https://doi.org/10.1016/s0140-6736(84)92852-6CrossRef

153.

Xiao YD, Paudel R, Liu J, Ma C, Zhang ZS, Zhou SK (2016) MRI contrast agents: classification and application (Review). Int J Mol Med 38(5):1319–1326. https://doi.org/10.3892/ijmm.2016.2744CrossRef

154.

Sherry AD, Caravan P, Lenkinski RE (2009) Primer on gadolinium chemistry. J Magn Resonan Imaging: JMRI 30(6):1240–1248. https://doi.org/10.1002/jmri.21966CrossRef

155.

Marasini R, Thanh Nguyen TD, Aryal S (2020) Integration of gadolinium in nanostructure for contrast enhanced-magnetic resonance imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 12(1):e1580. https://doi.org/10.1002/wnan.1580CrossRef

156.

Fraum TJ, Ludwig DR, Bashir MR, Fowler KJ (2017) Gadolinium-based contrast agents: a comprehensive risk assessment. J Magnetic Reson Imaging: JMRI 46(2):338–353. https://doi.org/10.1002/jmri.25625CrossRef

157.

Kahakachchi CL, Moore DA (2009) Speciation of gadolinium in gadolinium-based magnetic resonance imaging agents by high performance liquid chromatography inductively coupled plasma optical emission spectrometry. J Anal At Spectrom 24(10):1389. https://doi.org/10.1039/b907044cCrossRef

158.

Salehi B, Selamoglu Z, K SM, Pezzani R, Redaelli M, Cho WC, Kobarfard F, Rajabi S, Martorell M, Kumar P, Martins N, Subhra Santra T, Sharifi-Rad J (2019) Liposomal cytarabine as cancer therapy: from chemistry to medicine. Biomolecules 9(12). https://doi.org/10.3390/biom9120773

159.

Langereis S, Geelen T, Grull H, Strijkers GJ, Nicolay K (2013) Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery. NMR Biomed 26(7):728–744. https://doi.org/10.1002/nbm.2971CrossRef

160.

Liu X, Madhankumar AB, Miller PA, Duck KA, Hafenstein S, Rizk E, Slagle-Webb B, Sheehan JM, Connor JR, Yang QX (2016) MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA. Neuro Oncol 18(5):691–699. https://doi.org/10.1093/neuonc/nov263CrossRef

161.

Li W, Su B, Meng S, Ju L, Yan L, Ding Y, Song Y, Zhou W, Li H, Tang L, Zhao Y, Zhou C (2011) RGD-targeted paramagnetic liposomes for early detection of tumor: in vitro and in vivo studies. Eur J Radiol 80(2):598–606. https://doi.org/10.1016/j.ejrad.2011.01.051CrossRef

162.

Song Y, Li W, Meng S, Zhou W, Su B, Tang L, Zhao Y, Wu X, Yin D, Fan M, Zhou C (2018) Dual integrin alphavbeta 3 and NRP-1-targeting paramagnetic liposome for tumor early detection in magnetic resonance imaging. Nanoscale Res Lett 13(1):380. https://doi.org/10.1186/s11671-018-2797-6ADSCrossRef

163.

Hammoud DA (2016) Molecular imaging of inflammation: current status. J Nucl Med: Off Publ, Soc Nucl Med 57(8):1161–1165. https://doi.org/10.2967/jnumed.115.161182CrossRef

164.

Tian B, Liu R, Chen S, Chen L, Liu F, Jia G, Dong Y, Li J, Chen H, Lu J (2017) Mannose-coated gadolinium liposomes for improved magnetic resonance imaging in acute pancreatitis. Int J Nanomed 12:1127–1141. https://doi.org/10.2147/IJN.S123290CrossRef

165.

Dawood S (2010) Triple-negative breast cancer: epidemiology and management options. Drugs 70(17):2247–2258. https://doi.org/10.2165/11538150-000000000-00000CrossRef

166.

Goldman E, Zinger A, da Silva D, Yaari Z, Kajal A, Vardi-Oknin D, Goldfeder M, Schroeder JE, Shainsky-Roitman J, Hershkovitz D, Schroeder A (2017) Nanoparticles target early-stage breast cancer metastasis in vivo. Nanotechnology 28(43):43LT01. https://doi.org/10.1088/1361-6528/aa8a3d

167.

Kuijten MM, Hannah Degeling M, Chen JW, Wojtkiewicz G, Waterman P, Weissleder R, Azzi J, Nicolay K, Tannous BA (2015) Multimodal targeted high relaxivity thermosensitive liposome for in vivo imaging. Sci Rep 5:17220. https://doi.org/10.1038/srep17220ADSCrossRef

168.

Lorenzato C, Oerlemans C, van Elk M, Geerts WJ, Denis de Senneville B, Moonen C, Bos C (2016) MRI monitoring of nanocarrier accumulation and release using Gadolinium-SPIO co-labelled thermosensitive liposomes. Contrast Media Mol Imaging 11(3):184–194. https://doi.org/10.1002/cmmi.1679CrossRef

169.

Affram K, Udofot O, Singh M, Krishnan S, Reams R, Rosenberg J, Agyare E (2017) Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging. PLoS One 12(9):e0185116. https://doi.org/10.1371/journal.pone.0185116CrossRef

170.

Ahren M, Selegard L, Klasson A, Soderlind F, Abrikossova N, Skoglund C, Bengtsson T, Engstrom M, Kall PO, Uvdal K (2010) Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement. Langmuir: ACS J Surf Colloids 26(8):5753–5762. https://doi.org/10.1021/la903566yCrossRef

171.

Soderlind F, Pedersen H, Petoral RM Jr, Kall PO, Uvdal K (2005) Synthesis and characterisation of Gd2O3 nanocrystals functionalised by organic acids. J Colloid Interface Sci 288(1):140–148. https://doi.org/10.1016/j.jcis.2005.02.089ADSCrossRef

172.

Faucher L, Guay-Begin AA, Lagueux J, Cote MF, Petitclerc E, Fortin MA (2011) Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI. Contrast Media Mol Imaging 6(4):209–218. https://doi.org/10.1002/cmmi.420CrossRef

173.

Faucher L, Gossuin Y, Hocq A, Fortin MA (2011) Impact of agglomeration on the relaxometric properties of paramagnetic ultra-small gadolinium oxide nanoparticles. Nanotechnology 22(29):295103. https://doi.org/10.1088/0957-4484/22/29/295103CrossRef

174.

Park JY, Baek MJ, Choi ES, Woo S, Kim JH, Kim TJ, Jung JC, Chae KS, Chang Y, Lee GH (2009) Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images. ACS Nano 3(11):3663–3669. https://doi.org/10.1021/nn900761sCrossRef

175.

Bridot JL, Faure AC, Laurent S, Riviere C, Billotey C, Hiba B, Janier M, Josserand V, Coll JL, Elst LV, Muller R, Roux S, Perriat P, Tillement O (2007) Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc 129(16):5076–5084. https://doi.org/10.1021/ja068356jCrossRef

176.

Blumfield E, Swenson DW, Iyer RS, Stanescu AL (2019) Gadolinium-based contrast agents—review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients. Pediatr Radiol 49(4):448–457. https://doi.org/10.1007/s00247-018-4304-8CrossRef

177.

Pellico J, Ellis CM, Davis JJ (2019) Nanoparticle-based paramagnetic contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging 2019:1845637. https://doi.org/10.1155/2019/1845637CrossRef

178.

Cao Y, Xu L, Kuang Y, Xiong D, Pei R (2017) Gadolinium-based nanoscale MRI contrast agents for tumor imaging. J Mater Chem B 5(19):3431–3461. https://doi.org/10.1039/c7tb00382jCrossRef

179.

Miao X, Ho SL, Tegafaw T, Cha H, Chang Y, Oh IT, Yaseen AM, Marasini S, Ghazanfari A, Yue H, Chae KS, Lee GH (2018) Stable and non-toxic ultrasmall gadolinium oxide nanoparticle colloids (coating material = polyacrylic acid) as high-performance T1 magnetic resonance imaging contrast agents. RSC Adv 8(6):3189–3197. https://doi.org/10.1039/c7ra11830aADSCrossRef

180.

Mekuria SL, Debele TA, Tsai HC (2017) Encapsulation of gadolinium oxide nanoparticle (Gd2O3) contrasting agents in PAMAM dendrimer templates for enhanced magnetic resonance imaging in vivo. ACS Appl Mater Interfaces 9(8):6782–6795. https://doi.org/10.1021/acsami.6b14075CrossRef

181.

Rivlin M, Navon G (2016) Glucosamine and N-acetyl glucosamine as new CEST MRI agents for molecular imaging of tumors. Sci Rep 6:32648. https://doi.org/10.1038/srep32648ADSCrossRef

182.

Mortezazadeh T, Gholibegloo E, Riyahi Alam N, Haghgoo S, Musa A, E., Khoobi M (2020) Glucosamine conjugated gadolinium (III) oxide nanoparticles as a novel targeted contrast agent for cancer diagnosis in MRI. J Biomed Phys Eng 10(1):25–38. http://doi.org/10.31661/jbpe.v0i0.1018

183.

Mortezazadeh T, Gholibegloo E, Alam NR, Dehghani S, Haghgoo S, Ghanaati H, Khoobi M (2019) Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(beta-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies. MAGMA 32(4):487–500. https://doi.org/10.1007/s10334-019-00738-2CrossRef

184.

Wang Y, Yang T, Ke H, Zhu A, Wang Y, Wang J, Shen J, Liu G, Chen C, Zhao Y, Chen H (2015) Smart albumin-biomineralized nanocomposites for multimodal imaging and photothermal tumor ablation. Adv Mater 27(26):3874–3882. https://doi.org/10.1002/adma.201500229CrossRef

185.

Huang S, Liu J, Liu D, Yuan Q (2012) Facile and large-scale synthesis of Gd(OH)3 nanorods for MR imaging with low toxicity. New J Chem 36(6):1335. https://doi.org/10.1039/c2nj21009fCrossRef

186.

Yang Y, Sun Y, Liu Y, Peng J, Wu Y, Zhang Y, Feng W, Li F (2013) Long-term in vivo biodistribution and toxicity of Gd(OH)3 nanorods. Biomaterials 34(2):508–515. https://doi.org/10.1016/j.biomaterials.2012.09.075CrossRef

187.

Rajaee A, Wang S, Zhao L, Wang D, Liu Y, Wang J, Ying K (2019) Multifunction bismuth gadolinium oxide nanoparticles as radiosensitizer in radiation therapy and imaging. Phys Med Biol 64(19):195007. https://doi.org/10.1088/1361-6560/ab2154CrossRef

188.

Li IF, Su C-H, Sheu H-S, Chiu H-C, Lo Y-W, Lin W-T, Chen J-H, Yeh C-S (2008) Gd2O(CO3)2 H2O particles and the corresponding Gd2O3: synthesis and applications of magnetic resonance contrast agents and template particles for hollow spheres and hybrid composites. Adv Func Mater 18(5):766–776. https://doi.org/10.1002/adfm.200700702CrossRef

189.

Hu K-W, Jhang F-Y, Su C-H, Yeh C-S (2009) Fabrication of Gd2O(CO3)2 H2O/silica/gold hybrid particles as a bifunctional agent for MR imaging and photothermal destruction of cancer cells. J Mater Chem 19(15):2147. https://doi.org/10.1039/b815087gCrossRef

190.

Sook Choi E, Young Park J, Ju Baek M, Xu W, Kattel K, Hyun Kim J, Jun Lee J, Chang Y, Jeong Kim T, Eun Bae J, Seok Chae K, Jin Suh K (2010) Ho Lee G (2010) water-soluble ultra-small manganese oxide surface doped gadolinium oxide (Gd2O3@MnO) nanoparticles for MRI contrast agent. Eur J Inorg Chem 28:4555–4560. https://doi.org/10.1002/ejic.201000374CrossRef

191.

Tian X, Yang F, Yang C, Peng Y, Chen D, Zhu J, He F, Li L, Chen X (2014) Toxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo. Int J Nanomed 9:4043–4053. https://doi.org/10.2147/IJN.S66164CrossRef

192.

Yoon YS, Lee BI, Lee KS, Heo H, Lee JH, Byeon SH, Lee IS (2010) Fabrication of a silica sphere with fluorescent and MR contrasting GdPO4 nanoparticles from layered gadolinium hydroxide. Chem Commun 46(21):3654–3656. https://doi.org/10.1039/b927570cCrossRef

193.

Liu J, Tian X, Luo N, Yang C, Xiao J, Shao Y, Chen X, Yang G, Chen D, Li L (2014) Sub-10 nm monoclinic Gd2O3:Eu3+ nanoparticles as dual-modal nanoprobes for magnetic resonance and fluorescence imaging. Langmuir: ACS Journal Surf Coll 30(43):13005–13013. https://doi.org/10.1021/la503228vCrossRef

194.

Kamińska I, Fronc K, Sikora B, Mouawad M, Siemiarczuk A, Szewczyk M, Sobczak K, Wojciechowski T, Zaleszczyk W, Minikayev R, Paszkowicz W, Stępień P, Dziawa P, Ciszak K, Piątkowski D, Maćkowski S, Kaliszewski M, Włodarski M, Młyńczak J, Kopczyński K, Łapiński M, Elbaum D (2015) Upconverting/magnetic: Gd2O3:(Er3+, Yb3+, Zn2+) nanoparticles for biological applications: effect of Zn2+ doping. RSC Advances 5(95):78361–78373. https://doi.org/10.1039/c5ra11888cADSCrossRef

195.

Li H, Song S, Wang W, Chen K (2015) In vitro photodynamic therapy based on magnetic-luminescent Gd2O3:Yb, Er nanoparticles with bright three-photon up-conversion fluorescence under near-infrared light. Dalton Trans 44(36):16081–16090. https://doi.org/10.1039/c5dt01015bCrossRef

196.

Penfield JG, Reilly RF Jr (2007) What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 3(12):654–668. https://doi.org/10.1038/ncpneph0660CrossRef

197.

Herranz F, Morales MP, Rodríguez I, Ruiz-Cabello J (2017) Iron oxide nanoparticle-based mri contrast agents: characterization and in vivo use, pp 85–120. https://doi.org/10.1007/978-3-662-52780-1_3

198.

Shen Z, Wu A, Chen X (2017) Iron oxide nanoparticle based contrast agents for magnetic resonance imaging. Mol Pharm 14(5):1352–1364. https://doi.org/10.1021/acs.molpharmaceut.6b00839CrossRef

199.

Ling D, Hyeon T (2013) Chemical design of biocompatible iron oxide nanoparticles for medical applications. Small 9(9–10):1450–1466. https://doi.org/10.1002/smll.201202111CrossRef

200.

Jin R, Lin B, Li D, Ai H (2014) Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr Opin Pharmacol 18:18–27. https://doi.org/10.1016/j.coph.2014.08.002CrossRef

201.

Stephen ZR, Kievit FM, Zhang M (2011) Magnetite nanoparticles for medical MR imaging. Mater Today 14(7–8):330–338. https://doi.org/10.1016/s1369-7021(11)70163-8CrossRef

202.

Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A (2009) Magnetic resonance relaxation properties of superparamagnetic particles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1(3):299–310. https://doi.org/10.1002/wnan.36CrossRef

203.

Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108(6):2064–2110. https://doi.org/10.1021/cr068445eCrossRef

204.

Wang YX, Hussain SM, Krestin GP (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11(11):2319–2331. https://doi.org/10.1007/s003300100908CrossRef

205.

Lee H, Lee E, Kim DK, Jang NK, Jeong YY, Jon S (2006) Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J Am Chem Soc 128(22):7383–7389. https://doi.org/10.1021/ja061529kCrossRef

206.

Yu MK, Jeong YY, Park J, Park S, Kim JW, Min JJ, Kim K, Jon S (2008) Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew Chem 47(29):5362–5365. https://doi.org/10.1002/anie.200800857CrossRef

207.

Saraswathy A, Nazeer SS, Jeevan M, Nimi N, Arumugam S, Harikrishnan VS, Varma PR, Jayasree RS (2014) Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis. Coll Surf B Biointerfaces 117:216–224. https://doi.org/10.1016/j.colsurfb.2014.02.034CrossRef

208.

Liu D, Wu W, Ling J, Wen S, Gu N, Zhang X (2011) Effective PEGylation of iron oxide nanoparticles for high performance in vivo cancer imaging. Adv Func Mater 21(8):1498–1504. https://doi.org/10.1002/adfm.201001658CrossRef

209.

Ye F, Laurent S, Fornara A, Astolfi L, Qin J, Roch A, Martini A, Toprak MS, Muller RN, Muhammed M (2012) Uniform mesoporous silica coated iron oxide nanoparticles as a highly efficient, nontoxic MRI T(2) contrast agent with tunable proton relaxivities. Contrast Media Mol Imaging 7(5):460–468. https://doi.org/10.1002/cmmi.1473CrossRef

210.

Mahmoudi M, Hosseinkhani H, Hosseinkhani M, Boutry S, Simchi A, Journeay WS, Subramani K, Laurent S (2011) Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev 111(2):253–280. https://doi.org/10.1021/cr1001832CrossRef

211.

Andreas K, Georgieva R, Ladwig M, Mueller S, Notter M, Sittinger M, Ringe J (2012) Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. Biomaterials 33(18):4515–4525. https://doi.org/10.1016/j.biomaterials.2012.02.064CrossRef

212.

Azevedo-Pereira RL, Rangel B, Tovar-Moll F, Gasparetto EL, Attias M, Zaverucha-do-Valle C, Jasmin Mendez-Otero R (2019) Superparamagnetic iron oxide nanoparticles as a tool to track mouse neural stem cells in vivo. Mol Biol Rep 46(1):191–198. https://doi.org/10.1007/s11033-018-4460-9CrossRef

213.

Zare S, Mehrabani D, Jalli R, Saeedi Moghadam M, Manafi N, Mehrabani G, Jamhiri I, Ahadian S (2019) MRI-tracking of dental pulp stem cells in vitro and in vivo using dextran-coated superparamagnetic iron oxide nanoparticles. J Clin Med 8(9). https://doi.org/10.3390/jcm8091418

214.

Parkins KM, Makela AV, Hamilton AM, Foster PJ (2019) Cellular magnetic resonance imaging for tracking metastatic cancer cells in the brain. Methods Mol Biol 1869:239–251. https://doi.org/10.1007/978-1-4939-8805-1_20CrossRef

215.

Ashraf S, Taylor A, Sharkey J, Barrow M, Murray P, Wilm B, Poptani H, Rosseinsky MJ, Adams DJ, Lévy R (2019) In vivo fate of free and encapsulated iron oxide nanoparticles after injection of labelled stem cells. Nanoscale Adv 1(1):367–377. https://doi.org/10.1039/c8na00098kADSCrossRef

216.

Lee S, Yoon HI, Na JH, Jeon S, Lim S, Koo H, Han SS, Kang SW, Park SJ, Moon SH, Park JH, Cho YW, Kim BS, Kim SK, Lee T, Kim D, Lee S, Pomper MG, Kwon IC, Kim K (2017) In vivo stem cell tracking with imageable nanoparticles that bind bioorthogonal chemical receptors on the stem cell surface. Biomaterials 139:12–29. https://doi.org/10.1016/j.biomaterials.2017.05.050CrossRef

217.

Rosen JE, Chan L, Shieh DB, Gu FX (2012) Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomed Nanotechnol Biol Med 8(3):275–290. https://doi.org/10.1016/j.nano.2011.08.017CrossRef

218.

Li J, Zheng L, Cai H, Sun W, Shen M, Zhang G, Shi X (2013) Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging. Biomaterials 34(33):8382–8392. https://doi.org/10.1016/j.biomaterials.2013.07.070CrossRef

219.

Nyberg S, Abbott NJ, Shi X, Steyger PS, Dabdoub A (2019) Delivery of therapeutics to the inner ear: the challenge of the blood-labyrinth barrier. Sci Transl Med 11(482). https://doi.org/10.1126/scitranslmed.aao0935

220.

Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133–150. https://doi.org/10.1038/nrneurol.2017.188CrossRef

221.

Afzalipour R, Khoei S, Khoee S, Shirvalilou S, Jamali Raoufi N, Motevalian M, Karimi MR (2019) Dual-targeting temozolomide loaded in folate-conjugated magnetic triblock copolymer nanoparticles to improve the therapeutic efficiency of rat brain gliomas. ACS Biomater Sci Eng 5(11):6000–6011. https://doi.org/10.1021/acsbiomaterials.9b00856CrossRef

222.

Du C, Liu X, Hu H, Li H, Yu L, Geng D, Chen Y, Zhang J (2020) Dual-targeting and excretable ultrasmall SPIONs for T1-weighted positive MR imaging of intracranial glioblastoma cells by targeting the lipoprotein receptor-related protein. J Mater Chem B 8(11):2296–2306. https://doi.org/10.1039/c9tb02391gCrossRef

223.

Ashwinkumar N, Maya S, Jayakumar R (2014) Redox-responsive cystamine conjugated chitin–hyaluronic acid composite nanogels. RSC Adv 4(91):49547–49555. https://doi.org/10.1039/c4ra06578fADSCrossRef

224.

Ma D, Shi M, Li X, Zhang J, Fan Y, Sun K, Jiang T, Peng C, Shi X (2020) Redox-sensitive clustered ultrasmall iron oxide nanoparticles for switchable T2/T1-weighted magnetic resonance imaging applications. Bioconjug Chem 31(2):352–359. https://doi.org/10.1021/acs.bioconjchem.9b00659CrossRef

225.

Lin R, Huang J, Wang L, Li Y, Lipowska M, Wu H, Yang J, Mao H (2018) Bevacizumab and near infrared probe conjugated iron oxide nanoparticles for vascular endothelial growth factor targeted MR and optical imaging. Biomater Sci 6(6):1517–1525. https://doi.org/10.1039/c8bm00225hCrossRef

226.

Mattheolabakis G, Milane L, Singh A, Amiji MM (2015) Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. J Drug Target 23(7–8):605–618. https://doi.org/10.3109/1061186X.2015.1052072CrossRef

227.

Senbanjo LT, Chellaiah MA (2017) CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells. Front Cell Dev Biol 5:18. https://doi.org/10.3389/fcell.2017.00018CrossRef

228.

Zheng S, Han J, Jin Z, Kim CS, Park S, Kim KP, Park JO, Choi E (2018) Dual tumor-targeted multifunctional magnetic hyaluronic acid micelles for enhanced MR imaging and combined photothermal-chemotherapy. Coll Surf B Biointerfaces 164:424–435. https://doi.org/10.1016/j.colsurfb.2018.02.005CrossRef

229.

Murukesh N, Dive C, Jayson GC (2010) Biomarkers of angiogenesis and their role in the development of VEGF inhibitors. Br J Cancer 102(1):8–18. https://doi.org/10.1038/sj.bjc.6605483CrossRef

230.

Ferrara N, Hillan KJ, Novotny W (2005) Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 333(2):328–335. https://doi.org/10.1016/j.bbrc.2005.05.132CrossRef

231.

Zou Q, Zhang CJ, Yan YZ, Min ZJ, Li CS (2019) MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment. J Cell Biochem 120(11):18650–18658. https://doi.org/10.1002/jcb.28950CrossRef

232.

Gale EM, Wey HY, Ramsay I, Yen YF, Sosnovik DE, Caravan P (2018) A manganese-based alternative to gadolinium: contrast-enhanced MR angiography, excretion, pharmacokinetics, and metabolism. Radiology 286(3):865–872. https://doi.org/10.1148/radiol.2017170977CrossRef

233.

Pan D, Schmieder AH, Wickline SA, Lanza GM (2011) Manganese-based MRI contrast agents: past, present and future. Tetrahedron 67(44):8431–8444. https://doi.org/10.1016/j.tet.2011.07.076CrossRef

234.

McDonagh BH, Singh G, Hak S, Bandyopadhyay S, Augestad IL, Peddis D, Sandvig I, Sandvig A, Glomm WR (2016) L-DOPA-coated manganese oxide nanoparticles as dual MRI contrast agents and drug-delivery vehicles. Small 12(3):301–306. https://doi.org/10.1002/smll.201502545CrossRef

235.

Wang P, Yang J, Zhou B, Hu Y, Xing L, Xu F, Shen M, Zhang G, Shi X (2017) Antifouling manganese oxide nanoparticles: synthesis, characterization, and applications for enhanced MR imaging of tumors. ACS Appl Mater Interfaces 9(1):47–53. https://doi.org/10.1021/acsami.6b13844ADSCrossRef

236.

Venter A, Szulc DA, Loai S, Ganesh T, Haedicke IE, Cheng HM (2018) A manganese porphyrin-based T1 contrast agent for cellular MR imaging of human embryonic stem cells. Sci Rep 8(1):12129. https://doi.org/10.1038/s41598-018-30661-wADSCrossRef

237.

Kumar NA, Rejinold NS, Anjali P, Balakrishnan A, Biswas R, Jayakumar R (2013) Preparation of chitin nanogels containing nickel nanoparticles. Carbohydr Polym 97(2):469–474. https://doi.org/10.1016/j.carbpol.2013.05.009CrossRef

238.

Caro C, Garcia-Martin ML, Pernia Leal M (2017) Manganese-based nanogels as pH switches for magnetic resonance imaging. Biomacromolecules 18(5):1617–1623. https://doi.org/10.1021/acs.biomac.7b00224CrossRef

239.

Addisu KD, Hailemeskel BZ, Mekuria SL, Andrgie AT, Lin YC, Tsai HC (2018) Bioinspired, manganese-chelated alginate-polydopamine nanomaterials for efficient in vivo T1-weighted magnetic resonance imaging. ACS Appl Mater Interfaces 10(6):5147–5160. https://doi.org/10.1021/acsami.7b13396CrossRef

240.

Wang R, Luo Y, Yang S, Lin J, Gao D, Zhao Y, Liu J, Shi X, Wang X (2016) Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma. Sci Rep 6:33844. https://doi.org/10.1038/srep33844ADSCrossRef

241.

Li J, Wu C, Hou P, Zhang M, Xu K (2018) One-pot preparation of hydrophilic manganese oxide nanoparticles as T1 nano-contrast agent for molecular magnetic resonance imaging of renal carcinoma in vitro and in vivo. Biosens Bioelectron 102:1–8. https://doi.org/10.1016/j.bios.2017.10.047ADSCrossRef

242.

Ding X, Liu J, Li J, Wang F, Wang Y, Song S, Zhang H (2016) Polydopamine coated manganese oxide nanoparticles with ultrahigh relaxivity as nanotheranostic agents for magnetic resonance imaging guided synergetic chemo-/photothermal therapy. Chem Sci 7(11):6695–6700. https://doi.org/10.1039/c6sc01320aCrossRef

243.

Ragg R, Schilmann AM, Korschelt K, Wieseotte C, Kluenker M, Viel M, Volker L, Preiss S, Herzberger J, Frey H, Heinze K, Blumler P, Tahir MN, Natalio F, Tremel W (2016) Intrinsic superoxide dismutase activity of MnO nanoparticles enhances the magnetic resonance imaging contrast. J Mater Chem B 4(46):7423–7428. https://doi.org/10.1039/c6tb02078jCrossRef

244.

Zhan Y, Shi S, Ehlerding EB, Graves SA, Goel S, Engle JW, Liang J, Tian J, Cai W (2017) Radiolabeled, antibody-conjugated manganese oxide nanoparticles for tumor vasculature targeted positron emission tomography and magnetic resonance imaging. ACS Appl Mater Interfaces 9(44):38304–38312. https://doi.org/10.1021/acsami.7b12216CrossRef

245.

Yang L, Ma L, Xin J, Li A, Sun C, Wei R, Ren BW, Chen Z, Lin H, Gao J (2017) Composition tunable manganese ferrite nanoparticles for optimized T2 contrast ability. Chem Mater 29(7):3038–3047. https://doi.org/10.1021/acs.chemmater.7b00035CrossRef

246.

Augustine R, Lee HR, Kim H, Zhang Y, Kim I (2019) Hyperbranched lipopolymer-folate-stabilized manganese ferrite nanoparticles for the water-soluble targeted MRI contrast agent. React Funct Polym 144:104352. https://doi.org/10.1016/j.reactfunctpolym.2019.104352CrossRef

247.

Faraji S, Dini G, Zahraei M (2019) Polyethylene glycol-coated manganese-ferrite nanoparticles as contrast agents for magnetic resonance imaging. J Magn Magn Mater 475:137–145. https://doi.org/10.1016/j.jmmm.2018.11.097ADSCrossRef

248.

Li M, Zhao Q, Yi X, Zhong X, Song G, Chai Z, Liu Z, Yang K (2016) Au@MnS@ZnS Core/Shell/Shell nanoparticles for magnetic resonance imaging and enhanced cancer radiation therapy. ACS Appl Mater Interfaces 8(15):9557–9564. https://doi.org/10.1021/acsami.5b11588CrossRef

249.

Li XW, Zhao WR, Liu YJ, Liu XH, Shi P, Li YS, Shi JL (2016) Facile synthesis of manganese silicate nanoparticles for pH/GSH-responsive T1-weighted magnetic resonance imaging. J Mater Chem B 4(24):4313–4321. https://doi.org/10.1039/c6tb00718jCrossRef

250.

Cheng Y, Zhang S, Kang N, Huang J, Lv X, Wen K, Ye S, Chen Z, Zhou X, Ren L (2017) Polydopamine-coated manganese carbonate nanoparticles for amplified magnetic resonance imaging-guided photothermal therapy. ACS Appl Mater Interfaces 9(22):19296–19306. https://doi.org/10.1021/acsami.7b03087CrossRef

251.

Dasgupta A, Liu M, Ojha T, Storm G, Kiessling F, Lammers T (2016) Ultrasound-mediated drug delivery to the brain: principles, progress and prospects. Drug Discov Today Technol 20:41–48. https://doi.org/10.1016/j.ddtec.2016.07.007CrossRef

252.

Unger E, Shen D, Fritz T, Kulik B, Lund P, Wu GL, Yellowhair D, Ramaswami R, Matsunaga T (1994) Gas-filled lipid bilayers as ultrasound contrast agents. Invest Radiol 29(Suppl 2):S134–136. https://doi.org/10.1097/00004424-199406001-00044CrossRef

253.

Zhao YZ, Du LN, Lu CT, Jin YG, Ge SP (2013) Potential and problems in ultrasound-responsive drug delivery systems. Int J Nanomed 8:1621–1633. https://doi.org/10.2147/IJN.S43589CrossRef

254.

Alheshibri M, Craig VSJ (2019) Armoured nanobubbles; ultrasound contrast agents under pressure. J Coll Interface Sci 537:123–131. https://doi.org/10.1016/j.jcis.2018.10.108ADSCrossRef

255.

Yasuda K, Matsushima H, Asakura Y (2019) Generation and reduction of bulk nanobubbles by ultrasonic irradiation. Chem Eng Sci 195:455–461. https://doi.org/10.1016/j.ces.2018.09.044CrossRef

256.

Kalus M-R, Reimer V, Barcikowski S, Gökce B (2019) Discrimination of effects leading to gas formation during pulsed laser ablation in liquids. Appl Surf Sci 465:1096–1102. https://doi.org/10.1016/j.apsusc.2018.09.224ADSCrossRef

257.

Stride E, Edirisinghe M (2008) Novel microbubble preparation technologies. Soft Matter 4(12):2350. https://doi.org/10.1039/b809517pADSCrossRef

258.

Khan MS, Hwang J, Lee K, Choi Y, Kim K, Koo HJ, Hong JW, Choi J (2018) Oxygen-carrying micro/nanobubbles: composition, synthesis techniques and potential prospects in photo-triggered theranostics. Molecules 23(9). https://doi.org/10.3390/molecules23092210

259.

Alheshibri M, Qian J, Jehannin M, Craig VS (2016) A history of nanobubbles. Langmuir: ACS J Surf Coll 32(43):11086–11100. https://doi.org/10.1021/acs.langmuir.6b02489CrossRef

260.

Johnson BD, Cooke RC (1981) Generation of stabilized microbubbles in seawater. Science 213(4504):209–211. https://doi.org/10.1126/science.213.4504.209ADSCrossRef

261.

Kikuchi K, Ioka A, Oku T, Tanaka Y, Saihara Y, Ogumi Z (2009) Concentration determination of oxygen nanobubbles in electrolyzed water. J Coll Interface Sci 329(2):306–309. https://doi.org/10.1016/j.jcis.2008.10.009ADSCrossRef

262.

Kikuchi K, Nagata S, Tanaka Y, Saihara Y, Ogumi Z (2007) Characteristics of hydrogen nanobubbles in solutions obtained with water electrolysis. J Electroanal Chem 600(2):303–310. https://doi.org/10.1016/j.jelechem.2006.10.005CrossRef

263.

Ohgaki K, Khanh NQ, Joden Y, Tsuji A, Nakagawa T (2010) Physicochemical approach to nanobubble solutions. Chem Eng Sci 65(3):1296–1300. https://doi.org/10.1016/j.ces.2009.10.003CrossRef

264.

Cai WB, Yang HL, Zhang J, Yin JK, Yang YL, Yuan LJ, Zhang L, Duan YY (2015) The optimized fabrication of nanobubbles as ultrasound contrast agents for tumor imaging. Sci Rep 5:13725. https://doi.org/10.1038/srep13725ADSCrossRef

265.

Pan TL, Wang PW, Al-Suwayeh SA, Huang YJ, Fang JY (2012) Toxicological effects of cationic nanobubbles on the liver and kidneys: biomarkers for predicting the risk. Food Chem Toxicol 50(11):3892–3901. https://doi.org/10.1016/j.fct.2012.07.005CrossRef

266.

Mai L, Yao A, Li J, Wei Q, Yuchi M, He X, Ding M, Zhou Q (2013) Cyanine 5.5 conjugated nanobubbles as a tumor selective contrast agent for dual ultrasound-fluorescence imaging in a mouse model. PloS One 8(4):e61224. https://doi.org/10.1371/journal.pone.0061224

267.

Huang HY, Hu SH, Hung SY, Chiang CS, Liu HL, Chiu TL, Lai HY, Chen YY, Chen SY (2013) SPIO nanoparticle-stabilized PAA-F127 thermosensitive nanobubbles with MR/US dual-modality imaging and HIFU-triggered drug release for magnetically guided in vivo tumor therapy. J Controll Release: Off J Controll Release Soc 172(1):118–127. https://doi.org/10.1016/j.jconrel.2013.07.029CrossRef

268.

Huang HY, Liu HL, Hsu PH, Chiang CS, Tsai CH, Chi HS, Chen SY, Chen YY (2015) A multitheragnostic nanobubble system to induce blood-brain barrier disruption with magnetically guided focused ultrasound. Adv Mater 27(4):655–661. https://doi.org/10.1002/adma.201403889CrossRef

269.

Fan X, Wang L, Guo Y, Tu Z, Li L, Tong H, Xu Y, Li R, Fang K (2015) Ultrasonic nanobubbles carrying anti-PSMA nanobody: construction and application in prostate cancer-targeted imaging. PLoS One 10(6):e0127419. https://doi.org/10.1371/journal.pone.0127419CrossRef

270.

Peyman SA, McLaughlan JR, Abou-Saleh RH, Marston G, Johnson BR, Freear S, Coletta PL, Markham AF, Evans SD (2016) On-chip preparation of nanoscale contrast agents towards high-resolution ultrasound imaging. Lab Chip 16(4):679–687. https://doi.org/10.1039/c5lc01394aCrossRef

271.

Luke GP, Hannah AS, Emelianov SY (2016) Super-resolution ultrasound imaging in vivo with transient laser-activated nanodroplets. Nano Lett 16(4):2556–2559. https://doi.org/10.1021/acs.nanolett.6b00108ADSCrossRef

272.

Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452(7187):580–589. https://doi.org/10.1038/nature06917ADSCrossRef

273.

Weissleder R, Ntziachristos V (2003) Shedding light onto live molecular targets. Nat Med 9(1):123–128. https://doi.org/10.1038/nm0103-123CrossRef

274.

Hillman EMC, Amoozegar CB, Wang T, McCaslin AFH, Bouchard MB, Mansfield J, Levenson RM (2011) In vivo optical imaging and dynamic contrast methods for biomedical research. Philos Trans R Soc A: Math, Phys Eng Sci 369(1955):4620–4643. https://doi.org/10.1098/rsta.2011.0264ADSCrossRef

275.

Kosaka N, Ogawa M, Choyke PL, Kobayashi H (2009) Clinical implications of near-infrared fluorescence imaging in cancer. Future Oncol 5(9):1501–1511. https://doi.org/10.2217/fon.09.109CrossRef

276.

Reineck P, Gibson BC (2017) Near-infrared fluorescent nanomaterials for bioimaging and sensing. Adv Opt Mater 5(2):1600446. https://doi.org/10.1002/adom.201600446CrossRef

277.

Hahn MA, Singh AK, Sharma P, Brown SC, Moudgil BM (2011) Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives. Anal Bioanal Chem 399(1):3–27. https://doi.org/10.1007/s00216-010-4207-5CrossRef

278.

Choi HS, Frangioni JV (2010) Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol Imaging 9(6):291–310CrossRef

279.

Frangioni JV (2008) New technologies for human cancer imaging. J Clin Oncol 26(24):4012–4021. https://doi.org/10.1200/JCO.2007.14.3065CrossRef

280.

Debbage P, Jaschke W (2008) Molecular imaging with nanoparticles: giant roles for dwarf actors. Histochem Cell Biol 130(5):845–875. https://doi.org/10.1007/s00418-008-0511-yCrossRef

281.

Jaque D, Richard C, Viana B, Soga K, Liu X, García Solé J (2016) Inorganic nanoparticles for optical bioimaging. Adv Opt Photon 8(1):1–103. https://doi.org/10.1364/AOP.8.000001CrossRef

282.

Quek C-H, Leong KW (2012) Near-infrared fluorescent nanoprobes for in vivo optical imaging. Nanomater (Basel) 2(2):92–112. https://doi.org/10.3390/nano2020092CrossRef

283.

Ji X, Peng F, Zhong Y, Su Y, He Y (2014) Fluorescent quantum dots: Synthesis, biomedical optical imaging, and biosafety assessment. Coll Surf, B 124:132–139. https://doi.org/10.1016/j.colsurfb.2014.08.036ADSCrossRef

284.

Matea CT, Mocan T, Tabaran F, Pop T, Mosteanu O, Puia C, Iancu C, Mocan L (2017) Quantum dots in imaging, drug delivery and sensor applications. Int J Nanomed 12:5421–5431. https://doi.org/10.2147/IJN.S138624CrossRef

285.

Li J, Zhu J-J (2013) Quantum dots for fluorescent biosensing and bio-imaging applications. Analyst 138(9):2506–2515. https://doi.org/10.1039/C3AN36705CADSCrossRef

286.

Martynenko IV, Litvin AP, Purcell-Milton F, Baranov AV, Fedorov AV, Gun’ko YK (2017) Application of semiconductor quantum dots in bioimaging and biosensing. J Mater Chem B 5(33):6701–6727. https://doi.org/10.1039/C7TB01425BCrossRef

287.

Girma WM, Fahmi MZ, Permadi A, Abate MA, Chang J-Y (2017) Synthetic strategies and biomedical applications of I-III–VI ternary quantum dots. J Mater Chem B 5(31):6193–6216. https://doi.org/10.1039/C7TB01156CCrossRef

288.

Chen L-N, Wang J, Li W-T, Han H-Y (2012) Aqueous one-pot synthesis of bright and ultrasmall CdTe/CdS near-infrared-emitting quantum dots and their application for tumor targeting in vivo. Chem Commun 48(41):4971–4973. https://doi.org/10.1039/C2CC31259JCrossRef

289.

Narasimhan AK, Lakshmi BS, Santra TS, Rao MSR, Krishnamurthi G (2017) Oxygenated graphene quantum dots (GQDs) synthesized using laser ablation for long-term real-time tracking and imaging. RSC Adv 7(85):53822–53829. https://doi.org/10.1039/c7ra10702aADSCrossRef

290.

Gao D, Zhang P, Sheng Z, Hu D, Gong P, Chen C, Wan Q, Gao G, Cai L (2014) Highly bright and compact alloyed quantum rods with near infrared emitting: a potential multifunctional nanoplatform for multimodal imaging in vivo. Adv Func Mater 24(25):3897–3905. https://doi.org/10.1002/adfm.201304225CrossRef

291.

Ntziachristos V, Bremer C, Weissleder R (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13(1):195–208. https://doi.org/10.1007/s00330-002-1524-xCrossRef

292.

Kenry Duan Y, Liu B (2018) Recent advances of optical imaging in the second near-infrared window. Adv Mater 30(47):1802394. https://doi.org/10.1002/adma.201802394CrossRef

293.

Hong G, Antaris AL, Dai H (2017) Near-infrared fluorophores for biomedical imaging. Nat Biomed Eng 1(1):0010. https://doi.org/10.1038/s41551-016-0010CrossRef

294.

Chen G, Tian F, Zhang Y, Zhang Y, Li C, Wang Q (2014) Tracking of transplanted human mesenchymal stem cells in living mice using near-infrared Ag2S quantum dots. Adv Func Mater 24(17):2481–2488. https://doi.org/10.1002/adfm.201303263CrossRef

295.

Li C, Zhang Y, Wang M, Zhang Y, Chen G, Li L, Wu D, Wang Q (2014) In vivo real-time visualization of tissue blood flow and angiogenesis using Ag2S quantum dots in the NIR-II window. Biomaterials 35(1):393–400. https://doi.org/10.1016/j.biomaterials.2013.10.010CrossRef

296.

Abbasi E, Kafshdooz T, Bakhtiary M, Nikzamir N, Nikzamir N, Nikzamir M, Mohammadian M, Akbarzadeh A (2016) Biomedical and biological applications of quantum dots. Artif Cells, Nanomed, Biotechnol 44(3):885–891. https://doi.org/10.3109/21691401.2014.998826CrossRef

297.

Bannai H, Lévi S, Schweizer C, Dahan M, Triller A (2006) Imaging the lateral diffusion of membrane molecules with quantum dots. Nat Protoc 1(6):2628–2634. https://doi.org/10.1038/nprot.2006.429CrossRef

298.

Wen S, Zhou J, Zheng K, Bednarkiewicz A, Liu X, Jin D (2018) Advances in highly doped upconversion nanoparticles. Nat Commun 9(1):2415. https://doi.org/10.1038/s41467-018-04813-5ADSCrossRef

299.

Jiang S, Gnanasammandhan MK, Zhang Y (2010) Optical imaging-guided cancer therapy with fluorescent nanoparticles. J R Soc Interface 7(42):3–18. https://doi.org/10.1098/rsif.2009.0243CrossRef

300.

Wang F, Chatterjee DK, Li Z, Zhang Y, Fan X, Wang M (2006) Synthesis of polyethylenimine/NaYF4nanoparticles with upconversion fluorescence. Nanotechnology 17(23):5786–5791. https://doi.org/10.1088/0957-4484/17/23/013ADSCrossRef

301.

Lisiecki R, Ryba-Romanowski W, Speghini A, Bettinelli M (2009) Luminescence spectroscopy of Er3+-doped and Er3+, Yb3+ -codoped LaPO4 single crystals. J Lumin 129(5):521–525. https://doi.org/10.1016/j.jlumin.2008.12.006CrossRef

302.

Guo H, Qiao YM (2009) Preparation, characterization, and strong upconversion of monodisperse Y2O3:Er3+, Yb3+ microspheres. Opt Mater 31(4):583–589. https://doi.org/10.1016/j.optmat.2008.06.011ADSMathSciNetCrossRef

303.

Wu S, Han G, Milliron DJ, Aloni S, Altoe V, Talapin DV, Cohen BE, Schuck PJ (2009) Non-blinking and photostable upconverted luminescence from single lanthanide-doped nanocrystals. Proc Natl Acad Sci 106(27):10917. https://doi.org/10.1073/pnas.0904792106ADSCrossRef

304.

Wang F, Han Y, Lim CS, Lu Y, Wang J, Xu J, Chen H, Zhang C, Hong M, Liu X (2010) Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 463(7284):1061–1065. https://doi.org/10.1038/nature08777ADSCrossRef

305.

Chatterjee DK, Rufaihah AJ, Zhang Y (2008) Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 29(7):937–943. https://doi.org/10.1016/j.biomaterials.2007.10.051CrossRef

306.

Chen G, Qiu H, Prasad PN, Chen X (2014) Upconversion nanoparticles: design, nanochemistry, and applications in theranostics. Chem Rev 114(10):5161–5214. https://doi.org/10.1021/cr400425hCrossRef

307.

Park HS, Nam SH, Kim J, Shin HS, Suh YD, Hong KS (2016) Clear-cut observation of clearance of sustainable upconverting nanoparticles from lymphatic system of small living mice. Sci Rep 6(1):27407. https://doi.org/10.1038/srep27407ADSCrossRef

308.

Qiao R, Liu C, Liu M, Hu H, Liu C, Hou Y, Wu K, Lin Y, Liang J, Gao M (2015) Ultrasensitive in vivo detection of primary gastric tumor and lymphatic metastasis using upconversion nanoparticles. ACS Nano 9(2):2120–2129. https://doi.org/10.1021/nn507433pCrossRef

309.

Tian R, Zhao S, Liu G, Chen H, Ma L, You H, Liu C, Wang Z (2019) Construction of lanthanide-doped upconversion nanoparticle-Uelx Europaeus Agglutinin-I bioconjugates with brightness red emission for ultrasensitive in vivo imaging of colorectal tumor. Biomaterials 212:64–72. https://doi.org/10.1016/j.biomaterials.2019.05.010CrossRef

310.

Liang L, Chen N, Jia Y, Ma Q, Wang J, Yuan Q, Tan W (2019) Recent progress in engineering near-infrared persistent luminescence nanoprobes for time-resolved biosensing/bioimaging. Nano Res 12(6):1279–1292. https://doi.org/10.1007/s12274-019-2343-6CrossRef

311.

Brito HF, Hölsä J, Laamanen T, Lastusaari M, Malkamäki M, Rodrigues LCV (2012) Persistent luminescence mechanisms: human imagination at work. Opt Mater Express 2(4):371–381. https://doi.org/10.1364/OME.2.000371ADSCrossRef

312.

Liu J, Lécuyer T, Seguin J, Mignet N, Scherman D, Viana B, Richard C (2019) Imaging and therapeutic applications of persistent luminescence nanomaterials. Adv Drug Deliv Rev 138:193–210. https://doi.org/10.1016/j.addr.2018.10.015CrossRef

313.

Abdukayum A, Chen J-T, Zhao Q, Yan X-P (2013) Functional near infrared-emitting Cr3+/Pr3+Co-doped zinc gallogermanate persistent luminescent nanoparticles with superlong afterglow for in vivo targeted bioimaging. J Am Chem Soc 135(38):14125–14133. https://doi.org/10.1021/ja404243vCrossRef

314.

Jiang Y, Huang J, Zhen X, Zeng Z, Li J, Xie C, Miao Q, Chen J, Chen P, Pu K (2019) A generic approach towards afterglow luminescent nanoparticles for ultrasensitive in vivo imaging. Nat Commun 10(1):2064. https://doi.org/10.1038/s41467-019-10119-xADSCrossRef

315.

Attia ABE, Balasundaram G, Moothanchery M, Dinish US, Bi R, Ntziachristos V, Olivo M (2019) A review of clinical photoacoustic imaging: current and future trends. Photoacoustics 16:100144. https://doi.org/10.1016/j.pacs.2019.100144CrossRef

316.

Xia J, Wang LV (2014) Small-animal whole-body photoacoustic tomography: a review. IEEE Transac Bio-med Eng 61(5):1380–1389. https://doi.org/10.1109/TBME.2013.2283507CrossRef

317.

Wu D, Huang L, Jiang MS, Jiang H (2014) Contrast agents for photoacoustic and thermoacoustic imaging: a review. Int J Mol Sci 15(12):23616–23639. https://doi.org/10.3390/ijms151223616CrossRef

318.

Ku G, Wang LV (2005) Deeply penetrating photoacoustic tomography in biological tissues enhanced with an optical contrast agent. Opt Lett 30(5):507–509. https://doi.org/10.1364/OL.30.000507ADSCrossRef

319.

Pan D, Kim B, Wang LV, Lanza GM (2013) A brief account of nanoparticle contrast agents for photoacoustic imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 5(6):517–543. https://doi.org/10.1002/wnan.1231CrossRef

320.

Jiang Y, Pu K (2017) Advanced photoacoustic imaging applications of near-infrared absorbing organic nanoparticles. Small 13(30):1700710. https://doi.org/10.1002/smll.201700710CrossRef

321.

Maji SK, Sreejith S, Joseph J, Lin M, He T, Tong Y, Sun H, Yu SW-K, Zhao Y (2014) Upconversion nanoparticles as a contrast agent for photoacoustic imaging in live mice. Adv Mater 26(32):5633–5638. https://doi.org/10.1002/adma.201400831CrossRef

322.

Ding D, Guo W, Guo C, Sun J, Zheng N, Wang F, Yan M, Liu S (2017) MoO 3-x quantum dot for photoacoustic imaging guided photothermal/photodynamic cancer treatment. Nanoscale 8:1–3. https://doi.org/10.1039/C6NR09046JCrossRef

323.

Vaquero JJ, Kinahan P (2015) Positron emission tomography: current challenges and opportunities for technological advances in clinical and preclinical imaging systems. Annu Rev Biomed Eng 17:385–414. https://doi.org/10.1146/annurev-bioeng-071114-040723CrossRef

324.

Almuhaideb A, Papathanasiou N, Bomanji J (2011) 18F-FDG PET/CT imaging in oncology. Ann Saudi Med 31(1):3–13. https://doi.org/10.4103/0256-4947.75771CrossRef

325.

Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2(9):683–693. https://doi.org/10.1038/nrc882CrossRef

326.

Tu C, Ma X, House A, Kauzlarich SM, Louie AY (2011) PET imaging and biodistribution of silicon quantum dots in mice. ACS Med Chem Lett 2(4):285–288. https://doi.org/10.1021/ml1002844CrossRef

327.

Cheng S-H, Yu D, Tsai H-M, Morshed RA, Kanojia D, Lo L-W, Leoni L, Govind Y, Zhang L, Aboody KS, Lesniak MS, Chen C-T, Balyasnikova IV (2016) Dynamic in vivo spect imaging of neural stem cells functionalized with radiolabeled nanoparticles for tracking of glioblastoma. J Nucl Med 57(2):279–284CrossRef

Titel: Nanomaterials for Medical Imaging and In Vivo Sensing
verfasst von: N. Ashwin Kumar
B. S. Suresh Anand
Ganapathy Krishnamurthy
Verlag: Springer Singapore
Buch: Nanomaterials and Their Biomedical Applications
Print ISBN: 978-981-336-251-2

Electronic ISBN: 978-981-336-252-9

Copyright-Jahr: 2021
DOI: https://doi.org/10.1007/978-981-33-6252-9_13

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht

Bildnachweise

MKVS GbR/© MKVS GbR, Nordson/© Nordson, ViscoTec/© ViscoTec, BCD Chemie GmbH, Merz+Benteli/© Merz+Benteli, Robatech/© Robatech, Hermann Otto GmbH/© Hermann Otto GmbH, Ruderer Klebetechnik GmbH, Fere/© Fere, Xometry Europe GmbH/© Xometry Europe GmbH, Scheugenpflug/© Scheugenpflug, Sika/© Sika, Medmix/© Medmix, Kisling AG/© Kisling AG, Dosmatix GmbH/© Dosmatix GmbH, Innotech GmbH/© Innotech GmbH, Hilger u. Kern GmbH, VDI Logo/© VDI Wissensforum GmbH

Springer Professional

Abstract

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Springer Professional "Wirtschaft"

Marktübersichten